Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: Mol Cancer Res. 2015 Aug 6;14(1):3–13. doi: 10.1158/1541-7786.MCR-15-0189

Figure 2.

Figure 2

Process of using in vitro genomics for clinical treatment selection. Multiple prediction algorithms have been utilized to derive molecular features predictive of pharmacologic response of cells in vitro. After a tumor is biopsied and its genomic features are profiled, in vitro derived predictive signatures may be used to determine the best therapy for the individual’s tumor.